Formulation and Evaluation of Mucoadhesive Film-Forming Spray of Metronidazole for Localised Treatment of Periodontitis
International Journal of Drug Delivery Technology · 11.06.2026 · 16 (52s)
DOI: 10.25258/ijddt.16.52s.50 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 11.06.2026. Verfasst von Khushi Patel und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Periodontitis is a chronic inflammatory disease with a global prevalence of over one billion individuals, and the hallmark of the disease is progressive destruction of the tooth-supporting periodontium. Systemic metronidazole (MTZ) treatment produces subtherapeutic levels in the periodontal pocket and may result in gastrointestinal side effects and the development of antimicrobial resistance. Mucoadhesive film-forming delivery through a spray provides a noninvasive, patient-friendly delivery option.
Aim
To formulate and characterize a mucoadhesive film-forming spray (FFS) of metronidazole (0.25% w/v) based on polyvinyl alcohol (PVA) and carboxymethyl cellulose (CMC) as film-forming/mucoadhesive polymers, along with xanthan gum (XG) and propylene glycol, PEG 400 as the plasticizers in a hydroalcoholic system as vehicle.
Methods
A series of in total 13 formulations (B1–B13) were obtained by adjusting the polymer type and concentration, according to the established procedure. The preparations were tested for pH, viscosity, spray pattern, film-forming, uniformity of dosage, drying time, mucoadhesive strength and in vitro-release of drug (using semi-permeable membrane in phosphate buffer pH 6.8) through Franz diffusion cell. Quantification was performed by UV spectrophotometry at 277 nm.
Results
The pH of all the batches was within the physiological range of saliva (6.12–6.30). Viscosity (12 rpm) was between 24.6 and 82.5 cP, and consistent elliptical spray patterns were formed by B1–B5 and B7–B13. The batch B 12 (PVA 0.3%, CMC 0.3%, XG 0.1%, PEG 400 20%) showed the best results: drying time 28 ± 2s; mucoadhesive strength 0.42 ± 0.02 N/cm²; uniformity of dose 0.249 ± 0.003 mg/spray and biphasic drug release of 24.1% at 1 h and 57.3% at 4 h, more chronologically consistent with Higuchi diffusion kinetics.
Conclusion
The optimized mucoadhesive film-forming spray (Batch B12) can be considered as an efficient and patientcompliant actuation device for delivery of localized metronidazole for treatment of periodontitis, which quickly forms film in situ with prolonged antimicrobial activity and supports non-invasive adjunctive local drug delivery to periodontitis sites.
Zitieren
APA
Patel, K., Gholap, P., Hire, S., Patra, D., Pagare, D., Tak, G., & Lamb, A. (2026). Formulation and Evaluation of Mucoadhesive Film-Forming Spray of Metronidazole for Localised Treatment of Periodontitis. International Journal of Drug Delivery Technology, 16(52s). https://doi.org/10.25258/ijddt.16.52s.50
Vancouver
Patel K, Gholap P, Hire S, Patra D, Pagare D, Tak G, et al. Formulation and Evaluation of Mucoadhesive Film-Forming Spray of Metronidazole for Localised Treatment of Periodontitis. International Journal of Drug Delivery Technology. 2026;16(52s). doi:10.25258/ijddt.16.52s.50
BibTeX
@article{Patel2026,
author = {Patel, Khushi and Gholap, Pallavi and Hire, Sahil and Patra, Dipsha and Pagare, Dhiraj and Tak, Gautami and Lamb, Angeleena},
title = {Formulation and Evaluation of Mucoadhesive Film-Forming Spray of Metronidazole for Localised Treatment of Periodontitis},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {52s},
doi = {10.25258/ijddt.16.52s.50}
}
EUVIMED